Clinical trial
Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
NCT00432913 · S.L.A. Pharma AG, Industry · Completed
Key facts
| NCT number | NCT00432913 |
|---|---|
| Title | Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa |
| Official title | The Effect of Two Dose Levels of Eicosapentaenoic Acid (EPA) on Apoptosis and Cell Proliferation in the Colonic Mucosa of Patients With a History of Colonic Polyps. |
| Lead sponsor | S.L.A. Pharma AG, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Adenomatous Polyps |
| Intervention type | Drug, Procedure |
| Interventions | Eicosapentaenoic Acid (EPA), Endoscopy, Biopsies taken, Clinical chemistry, Haematology, Physical examination, Vital signs, Urine pregnancy test, Completion of patient diary card |
| Enrollment | 120 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 8, 2007 |
| Last update posted | Oct 17, 2008 |
| Countries | Italy, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: